Table 1.
Participant characteristics
| Characteristic | Round 1, n (%) | Round 2, n (%) | Round 3, n (%) |
|---|---|---|---|
| Surveys sent, n | 90 | 90 | 68 |
| Total respondents | 70 (77.8) | 68 (75.6) | 60 (88.2) |
| Participant type | |||
| Researchers | 33 (47.1) | 29 (42.6) | 28 (46.7) |
| Expertise | |||
| CKD | 7(21.2) | 7 (24.1) | 7 (25.0) |
| ESRD | 23 (69.7) | 20 (69.0) | 19 (67.9) |
| CKD/ESRD | 3 (9.1) | 2 (6.9) | 2 (7.1) |
| Policymakers | 13 (18.6) | 13 (19.1) | 11 (18.3) |
| Patients | 9 (12.9) | 11 (16.2) | 7 (11.7) |
| Clinicians | 15 (21.4) | 15 (22.1) | 14 (23.3) |
| Exercise specialist | 7 (46.7) | 9 (60.0) | 9 (64.3) |
| Nephrologist | 5 (33.3) | 4 (26.7) | 3 (21.4) |
| Nurse | 2 (13.3) | 2 (13.3) | 2 (14.3) |
| Other health care provider | 1 (6.7) | 0 (0) | 0 (0) |
| Age, yr | |||
| <35 | 12 (17.1) | 12 (17.6) | 12 (20.0) |
| 36–50 | 28 (40.0) | 25 (36.8) | 21 (35.0) |
| 51–65 | 27 (38.6) | 28 (41.2) | 24 (40.0) |
| >65 | 3 (4.3) | 3 (4.4) | 3 (5.0) |
| Gender | |||
| Female | 35 (50.0) | 34 (50.0) | 30 (50.0) |
| Male | 35 (50.0) | 33 (48.5) | 30 (50.0) |
| Declined to answer | 0 (0) | 1 (1.5) | 0 (0) |
| Continent | |||
| Asia | 1 (1.4) | 1 (1.5) | 1 (1.7) |
| Europe | 19 (27.1) | 16 (23.5) | 14 (23.3) |
| North America | 42 (60.0) | 44 (64.7) | 38 (63.3) |
| Oceania | 7 (10.0) | 6 (8.8) | 6 (10.0) |
| South America | 1 (1.4) | 1 (1.5) | 1 (1.7) |
CKD, chronic kidney disease; ESRD, end-stage renal disease.